Robson CN - Search Results

1

Human ex vivo prostate tissue model system identifies ING3 as an oncoprotein.

McClurg UL, Nabbi A, Ricordel C, Korolchuk S, McCracken S, Heer R, Wilson L, Butler LM, Irving-Hooper BK, Pedeux R, Robson CN, Riabowol KT, Binda O. McClurg UL, et al. Among authors: robson cn. Br J Cancer. 2018 Mar 6;118(5):713-726. doi: 10.1038/bjc.2017.447. Epub 2018 Jan 30. Br J Cancer. 2018. PMID: 29381681 Free PMC article.

2

Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies.

Autzen P, Robson CN, Bjartell A, Malcolm AJ, Johnson MI, Neal DE, Hamdy FC. Autzen P, et al. Among authors: robson cn. Br J Cancer. 1998 Nov;78(9):1219-23. doi: 10.1038/bjc.1998.658. Br J Cancer. 1998. PMID: 9820184 Free PMC article.

3

Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer.

Gnanapragasam VJ, Leung HY, Pulimood AS, Neal DE, Robson CN. Gnanapragasam VJ, et al. Among authors: robson cn. Br J Cancer. 2001 Dec 14;85(12):1928-36. doi: 10.1054/bjoc.2001.2179. Br J Cancer. 2001. PMID: 11747336 Free PMC article.

4

FGF8 isoform b expression in human prostate cancer.

Gnanapragasam VJ, Robinson MC, Marsh C, Robson CN, Hamdy FC, Leung HY. Gnanapragasam VJ, et al. Among authors: robson cn. Br J Cancer. 2003 May 6;88(9):1432-8. doi: 10.1038/sj.bjc.6600875. Br J Cancer. 2003. PMID: 12778074 Free PMC article.

5

Fibroblast growth factor 17 is over-expressed in human prostate cancer.

Heer R, Douglas D, Mathers ME, Robson CN, Leung HY. Heer R, et al. Among authors: robson cn. J Pathol. 2004 Dec;204(5):578-86. doi: 10.1002/path.1668. J Pathol. 2004. PMID: 15538740

6

Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer.

Gowardhan B, Douglas DA, Mathers ME, McKie AB, McCracken SR, Robson CN, Leung HY. Gowardhan B, et al. Among authors: robson cn. Br J Cancer. 2005 Jan 31;92(2):320-7. doi: 10.1038/sj.bjc.6602274. Br J Cancer. 2005. PMID: 15655558 Free PMC article.

7

Epigenetic inactivation of the human sprouty2 (hSPRY2) homologue in prostate cancer.

McKie AB, Douglas DA, Olijslagers S, Graham J, Omar MM, Heer R, Gnanapragasam VJ, Robson CN, Leung HY. McKie AB, et al. Among authors: robson cn. Oncogene. 2005 Mar 24;24(13):2166-74. doi: 10.1038/sj.onc.1208371. Oncogene. 2005. PMID: 15735753

8

Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptors.

Mills IG, Gaughan L, Robson C, Ross T, McCracken S, Kelly J, Neal DE. Mills IG, et al. J Cell Biol. 2005 Jul 18;170(2):191-200. doi: 10.1083/jcb.200503106. J Cell Biol. 2005. PMID: 16027218 Free PMC article.

9

KGF suppresses alpha2beta1 integrin function and promotes differentiation of the transient amplifying population in human prostatic epithelium.

Heer R, Collins AT, Robson CN, Shenton BK, Leung HY. Heer R, et al. Among authors: robson cn. J Cell Sci. 2006 Apr 1;119(Pt 7):1416-24. doi: 10.1242/jcs.02802. J Cell Sci. 2006. PMID: 16554439

10

Human PIRH2 enhances androgen receptor signaling through inhibition of histone deacetylase 1 and is overexpressed in prostate cancer.

Logan IR, Gaughan L, McCracken SR, Sapountzi V, Leung HY, Robson CN. Logan IR, et al. Among authors: robson cn. Mol Cell Biol. 2006 Sep;26(17):6502-10. doi: 10.1128/MCB.00147-06. Mol Cell Biol. 2006. PMID: 16914734 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

176 results

Search Page